Barcelona Institute for Global Health news release
A clinical trial conducted in Tanzania and Mozambique and published in The Lancet Infectious Diseases concluded that expanding the use of molecular diagnostic tests on urine and stool samples, in addition to sputum, to detect TB in hospitalised people living with HIV does not improve early treatment initiation nor reduce short-term mortality.
The study aimed to assess the integration of new molecular tests into current WHO-recommended diagnostic strategies.
Read the full news release here.
For more TB updates, check out the TB CAB Weekly Newsletter (Issue #15, 17 May 2026).
The newsletter is brought to you by the Global TB Community Advisory Board (TB CAB) with the support of Treatment Action Group (TAG) and the European AIDS Treatment Group (EATG). Subscribe to the newsletter here.
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.